Skip to main content
. 2021 Apr 9;13(8):1806. doi: 10.3390/cancers13081806

Table 1.

Patient characteristics.

Characteristics Number %
Age
Median (IQR) 48 (42–54)
Hypertension
No 215 87.40%
Yes 31 12.60%
Diabetes mellitus
No 229 93.10%
Yes 17 6.90%
Exercise
No 175 71.10%
Yes 71 28.90%
Weight change
No change 211 85.80%
Decrease 14 5.70%
Increase 21 8.50%
Smoking status
Non-smoker 241 98.00%
Current smoker 4 1.60%
Ex-smoker 1 0.40%
Drinking status
Non-drinker 219 88.90%
Current drinker 21 8.60%
Ex-drinker 6 2.50%
Skeletal muscle mass_pre-NAC
Skeletal muscle loss 30 12.20%
Non-skeletal muscle loss 216 87.80%
Skeletal muscle mass_post-NAC
Skeletal muscle loss 33 13.50%
Non-skeletal muscle loss 213 86.50%
Change in skeletal muscle mass
Skeletal muscle loss → Skeletal muscle loss 18 7.30%
Skeletal muscle loss → Non-skeletal muscle loss 12 4.90%
Non-skeletal muscle loss → Skeletal muscle loss 15 6.10%
Non-skeletal muscle loss → Non-skeletal muscle loss 201 81.70%
Body mass index
Underweight (<18.5) 8 3.30%
Normal (18.5–23) 128 52.00%
Overweight (23–25) 43 17.50%
Obese (≥25) 67 27.20%
Hemoglobin
Median (IQR) 13.2 (12.5–13.9)
Platelets
Median (IQR) 268 (229–312)
Albumin
Median (IQR) 4.5 (4.3–4.6)
Protein
Median (IQR) 7.4 (7.1–7.7)

Abbreviations: IQR, Interquartile range; NAC, Neoadjuvant chemotherapy.